ArticleAntibiotics (Basel, Switzerland)2020
Beta-Lactamase-Producing
Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Prioritising intervention areas for antimicrobial resistance in Nigeria's human and animal health sectors using a mixed-methods approach.One health (Amsterdam, Netherlands) · 2025Article
- Environmental Risk Factors Contributing to the Spread of Antibiotic Resistance in West Africa.Microorganisms · 2025Review
- Molecular identification of tetracycline resistance genes inOpen veterinary journal · 2025Review
- Multi-drug resistant (MDR) and extended-spectrum β-lactamase (ESBL) producingOne health (Amsterdam, Netherlands) · 2024Article
- Exploring Extended-Spectrum Beta-Lactamase (ESBL)-ProducingPathogens (Basel, Switzerland) · 2024Review
- Carbapenem Resistance in Animal-Environment-Food from Africa: A Systematic Review, Recommendations and Perspectives.Infection and drug resistance · 2024Review
- Knowledge and self-reported food safety practices among meat consumers in Ilorin, Nigeria.Dialogues in health · 2022Article
- Prevalence and Molecular Characterization of Extended-Spectrum β-Lactamases and AmpC β-lactamase-ProducingPathogens (Basel, Switzerland) · 2022Article
- Article
- Extended-Spectrum ß-Lactamase-ProducingFrontiers in cellular and infection microbiology · 2022Article
- Improving Food Safety Culture in Nigeria: A Review of Practical Issues.Foods (Basel, Switzerland) · 2021Review
- Prevalence and risk factors for faecal carriage of multidrug resistant Escherichia coli among slaughterhouse workers.Scientific reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic resistance evolution among pathogenic microorganisms has become a huge burden globally as it has increased the burden of diseases amongst humans and animals. The prevalence of extended-spectrum beta-lactamase-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.